research What is the best treatment for androgenic alopecia?
Dutasteride 0.5 mg/day is the best treatment for male pattern baldness.
Search
forProducts matching "minoxidil dutasteride"
Tracking 3 products like 118 REGROWTH LABS 7HP, 120 REGROWTH LABS D5A and 132 URODART 0.5MG 28 capsule from by companies like Minoxidil Express. View all 3 products »
Sort by
Research
120-150 / 1000+ results 
research What is the best treatment for androgenic alopecia?
Dutasteride 0.5 mg/day is the best treatment for male pattern baldness.
research Combined Regenerative Technique: Tattoo Machine–Assisted Drug Delivery for Androgenetic Alopecia
Tattoo machine-assisted drug delivery may improve hair growth in androgenetic alopecia.
research Farmácia dos Clérigos - Porto e nos Serviços Farmacêuticos da University College Hospital - Londres, Reino Unido, ao abrigo do programa Erasmus+
Pharmacists play a crucial role in improving patient outcomes through personalized care and staying updated with scientific advancements.
research COMPLICAÇÕES DOS TRATAMENTOS DA ALOPÉCIA ANDROGÉNICA: REVISÃO SISTEMÁTICA E META-ANÁLISE
Androgenetic alopecia treatments slightly increase the risk of side effects, especially sexual dysfunction and skin reactions.
research Revisión y avances en tricología
Recent advancements in hair loss treatments include new therapies and insights for different types of alopecia.
research Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
Alopesi tedavisinde ilaçlar saç büyümesini teşvik eder ve yeni yaklaşımlar umut vaat eder.
research NUMERICAL DESCRIPTOR COMPUTATION OF ALOPECIA DRUGS USING COM – POLYNOMIAL
Numerical methods help analyze alopecia drugs' properties effectively.
research Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.
research A eficácia da mesoterapia em tratamentos de alopecia: revisão integrativa da literatura
Mesotherapy shows promise for treating alopecia but needs more research for long-term effectiveness.
research Anti-Hair Loss Potential of Perilla Seed Extracts: In Vitro Molecular Insights from Supercritical Fluid Extraction
Perilla seed extract may help prevent hair loss better than some standard treatments.
research Hair loss treatments: A Google trends analysis worldwide of the past 5 years (2018-2023)
Interest in hair loss treatments, especially Minoxidil and Finasteride, has increased globally, with variations by region.
research Nanotechnology-based topical treatments for androgenic alopecia
Nanotechnology could improve hair loss treatments by delivering drugs more effectively.
research Male and female pattern hair loss
Hair loss in men and women can be treated with medications and therapies, showing improvement after 6 months.
research Androgenetic alopecia - a literature review
Combination therapies for androgenetic alopecia are more effective, but more research is needed for safe, standardized treatments.
research Mesotherapy in Androgenetic Alopecia: A Comprehensive Review of Active Ingredients, Protocols, and Clinical Efficacy
Mesotherapy can improve hair growth in androgenetic alopecia but needs more research for standard use.
research Management of Androgenetic Alopecia in Men in 2025: A Focused Review
Personalized treatment plans are crucial for effectively managing male pattern baldness.
research Male androgenetic alopecia
Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.
research Updates in Treatment for Androgenetic Alopecia
New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.
research Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto
Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.
research 5-Alpha-Reductase Inhibitors in the Treatment of Male Androgenetic Alopecia: Clinical Experience
Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.
research A bibliometric analysis of alternative drug therapy options in the treatment of androgenetic alopecia
Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.
research The impact of monotherapies for male androgenetic alopecia: A network meta‐analysis study
"Dutasteride 0.5 mg daily is the most effective treatment for male hair loss."
research Recomendaciones sobre el manejo clínico de la alopecia androgénica: un documento de consenso del Grupo Español de Tricología de la Academia Española de Dermatología y Venereología
Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.
research Efficacy and safety of combined microneedling therapy for androgenic alopecia: A systematic review and meta‐analysis of randomized clinical trials
Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.
research Androgenic alopecia and differential diagnoses of alopecia
Androgenic alopecia is hereditary hair loss treated with medications, therapies, and support.
research The diagnosis and treatment of androgenetic alopecia: a review of the most current management
Various treatments for common hair loss in men and women are effective, but should be tailored to individual needs and potential side effects.
research Epidemiologic Study of Gene Distribution in Romanian and Brazilian Patients with Non-Cicatricial Alopecia
The study suggests that analyzing DNA can help treat hair loss, but more research is needed.
research Investigations of 13 Genes in Non-Cicatricial Alopecia
DNA analysis can help tailor alopecia treatment.
research Androgenetic alopecia: An update
Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.